José L Jiménez (Jose L Jimenez)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Network Analysis

Magnetic Resonance

Top Venues

Biometrical journal. Biometrische Zeitschrift

Pharmaceutical statistics

Brazilian journal of biometrics

This page only lists publications with an associated author ORCID identifier.

Publications

José L Jiménez, Isobel Barrott, Francesca Gasperoni, Dominic Magirr
Visualizing hypothesis tests in survival analysis under anticipated delayed effects. Pharmaceutical statistics (2024)
Dominic Magirr, José L Jiménez
Stratified modestly weighted log-rank tests in settings with an anticipated delayed separation of survival curves. Biometrical journal. Biometrische Zeitschrift (2023)
José L Jiménez, Haiyan Zheng
A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages. Biometrical journal. Biometrische Zeitschrift (2023)
Mourad Tighiouart, José L Jiménez, Marcio Augusto Diniz, André Rogatko
Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value? Brazilian journal of biometrics 40 (4) (2022)
Dominic Magirr, José L Jiménez
Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidance. Clinical trials (London, England) 19 (2) (2022)
Mourad Tighiouart, José L Jiménez, Marcio Augusto Diniz, André Rogatko
Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value? Brazilian journal of biometrics 40 (4) (2022)
José L Jiménez, Julia Niewczas, Alexander Bore, Carl-Fredrik Burman
A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching. PloS one 16 (11) (2021)
José L Jiménez, Viktoriya Stalbovskaya, Byron Jones
Response to comments on "Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects" by José L. Jiménez, Viktoriya Stalbovskaya and Byron Jones, Pharmaceutical Statistics, 2019; 18:287-303, DOI: 10.1002/pst.1923. Pharmaceutical statistics 19 (5) (2020)
José L Jiménez, Sungjin Kim, Mourad Tighiouart
A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations. Biometrical journal. Biometrische Zeitschrift 62 (5) (2020)
José L Jiménez
Quantifying treatment differences in confirmatory trials under non-proportional hazards. Journal of applied statistics 49 (2) (2020)
José L Jiménez, Mourad Tighiouart, Mauro Gasparini
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents. Biometrical journal. Biometrische Zeitschrift 61 (2) (2018)
José L Jiménez, Viktoriya Stalbovskaya, Byron Jones
Properties of the weighted log-rank test in the design of confirmatory studies with delayed effects. Pharmaceutical statistics 18 (3) (2018)